Key Takeaways
- • Ownership transition completed: L Catterton and Altas Partners have acquired a majority stake in Fullscript from original investors HGGC and Snapdragon Capital Partners, marking a significant exit for the founding PE firms after their initial 2021 investment.
- • Leonard Green & Partners leads continuation vehicle: Leonard Green & Partners serves as the sole lead investor in a continuation fund backing the transaction, providing fresh capital to support Fullscript's next growth phase while existing investors maintain partial exposure.
- • Strong operational momentum: Fullscript now supports over 100,000 healthcare providers and 10 million patients across its platform, positioning the company as a scaled player in the whole-person care technology market.
- • Healthcare platform focus: The company operates a digital ecosystem offering evidence-based supplement prescribing, lab management capabilities, and patient adherence tools—addressing a fragmented market at the intersection of preventative care and provider-patient engagement.
- • Multiple PE backing signals confidence: The transaction sequence—from HGGC/Snapdragon's initial $240 million investment in 2021, to additional capital in May 2025, to the current majority stake acquisition—reflects consistent institutional confidence in the business model and scaling trajectory.
Summary
Fullscript, a healthcare technology platform headquartered in Ottawa, has undergone an ownership change with L Catterton and Altas Partners acquiring a majority stake from HGGC and Snapdragon Capital Partners. The transaction represents a structured exit for the original investors while introducing new institutional backing to accelerate growth. Leonard Green & Partners has established a continuation vehicle as the sole lead investor, providing capital to support the company's next phase of expansion. This structure allows existing investors to maintain partial exposure to the business while enabling new capital to flow toward growth initiatives.
The company was originally backed by HGGC with Snapdragon as a minority investor starting in 2021, when they deployed a $240 million growth investment. Both firms made additional investments in May 2025, with Leonard Green & Partners participating through a GP-led secondary transaction. The current majority stake acquisition by L Catterton and Altas Partners signals a transition to new operational and strategic leadership while maintaining continuity through the continuation vehicle framework.
Founded in 2011, Fullscript has built substantial scale within the digital health and wellness sector. The platform now serves over 100,000 healthcare providers and reaches approximately 10 million patients. The company's core offering centers on empowering providers with tools for evidence-based supplement prescribing and fulfillment, advanced lab management capabilities, and solutions designed to improve patient adherence and health outcomes. According to Kyle Braatz, Co-Founder and CEO, the company is "transforming how care is delivered by bridging the gap between providers and patients with a truly whole-person approach." This positioning addresses a growing market segment focused on preventative and integrative care models rather than traditional acute-care delivery.
The involvement of multiple sophisticated institutional investors—HGGC, Snapdragon, Leonard Green & Partners, L Catterton, and Altas Partners—underscores strong confidence in Fullscript's business model and market opportunity. The repeated capital deployments and structured continuation approach suggest confidence in management execution and the company's ability to capture further market share in the healthcare provider technology space, particularly as demand for integrated, patient-centric care platforms continues to expand.
The company was originally backed by HGGC with Snapdragon as a minority investor starting in 2021, when they deployed a $240 million growth investment. Both firms made additional investments in May 2025, with Leonard Green & Partners participating through a GP-led secondary transaction. The current majority stake acquisition by L Catterton and Altas Partners signals a transition to new operational and strategic leadership while maintaining continuity through the continuation vehicle framework.
Founded in 2011, Fullscript has built substantial scale within the digital health and wellness sector. The platform now serves over 100,000 healthcare providers and reaches approximately 10 million patients. The company's core offering centers on empowering providers with tools for evidence-based supplement prescribing and fulfillment, advanced lab management capabilities, and solutions designed to improve patient adherence and health outcomes. According to Kyle Braatz, Co-Founder and CEO, the company is "transforming how care is delivered by bridging the gap between providers and patients with a truly whole-person approach." This positioning addresses a growing market segment focused on preventative and integrative care models rather than traditional acute-care delivery.
The involvement of multiple sophisticated institutional investors—HGGC, Snapdragon, Leonard Green & Partners, L Catterton, and Altas Partners—underscores strong confidence in Fullscript's business model and market opportunity. The repeated capital deployments and structured continuation approach suggest confidence in management execution and the company's ability to capture further market share in the healthcare provider technology space, particularly as demand for integrated, patient-centric care platforms continues to expand.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.